Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-09

Clinical Trial Update: AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide Alone [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the addition of rosiglitazone (Avandia) to glyburide in African American and Hispanic patients with Type 2 diabetes mellitus not contro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avandia (rosiglitazone)
  • Glyburide (glyburide)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED